|
|
|
|
LEADER |
01265nam a2200253 u 4500 |
001 |
EB002000983 |
003 |
EBX01000000000000001163884 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
210907 r ||| eng |
100 |
1 |
|
|a Yeung, Shirley S. T.
|
245 |
0 |
0 |
|a Coated and uncoated central venous catheters
|h Elektronische Ressource
|b a review of comparative clinical effectiveness and safety
|c Shirley S.T. Yeung, Hannah Loshak
|
250 |
|
|
|a Version 1.0
|
260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c 2019, January 15, 2019
|
300 |
|
|
|a 1 PDF file (22 pages)
|b illustration
|
505 |
0 |
|
|a Includes bibliographical references
|
700 |
1 |
|
|a Loshak, Hannah
|e [author]
|
710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK541236
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a The objective of this review is to assess the comparative clinical effectiveness, as well as harms and safety, between coated central venous catheters (CVCs) and uncoated CVCs for critically ill adult patients
|